Clinical Trial Update: Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed a three-drug antiemetic regimen (aprepitant plus a 5-HT3 antagonist and dexamethasone) in patients with germ cell tumors; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Ondansetron (ondansetron)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Germ Cell Tumors | Phase 3 | Status: COMPLETED | Results posted: 2016-04-06